Literature DB >> 30327381

Zebrafish: Speeding Up the Cancer Drug Discovery Process.

Patricia Letrado1,2, Irene de Miguel2, Iranzu Lamberto1, Roberto Díez-Martínez3, Julen Oyarzabal4.   

Abstract

Zebrafish (Danio rerio) is an ideal in vivo model to study a wide variety of human cancer types. In this review, we provide a comprehensive overview of zebrafish in the cancer drug discovery process, from (i) approaches to induce malignant tumors, (ii) techniques to monitor cancer progression, and (iii) strategies for compound administration to (iv) a compilation of the 355 existing case studies showing the impact of zebrafish models on cancer drug discovery, which cover a broad scope of scenarios. Finally, based on the current state-of-the-art analysis, this review presents some highlights about future directions using zebrafish in cancer drug discovery and the potential of this model as a prognostic tool in prospective clinical studies. Cancer Res; 78(21); 6048-58. ©2018 AACR. ©2018 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30327381     DOI: 10.1158/0008-5472.CAN-18-1029

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  40 in total

Review 1.  Pediatric Cancer Models in Zebrafish.

Authors:  Mattie J Casey; Rodney A Stewart
Journal:  Trends Cancer       Date:  2020-03-13

Review 2.  Zebrafish patient avatars in cancer biology and precision cancer therapy.

Authors:  Maurizio Fazio; Julien Ablain; Yan Chuan; David M Langenau; Leonard I Zon
Journal:  Nat Rev Cancer       Date:  2020-04-06       Impact factor: 60.716

Review 3.  Zebrafish-An Optimal Model in Experimental Oncology.

Authors:  Iwona Kwiatkowska; Justyna Magdalena Hermanowicz; Zaneta Iwinska; Krystyna Kowalczuk; Jolanta Iwanowska; Dariusz Pawlak
Journal:  Molecules       Date:  2022-06-30       Impact factor: 4.927

4.  Development of a cancer cells self‑activating and miR‑125a‑5p expressing poly‑pharmacological nanodrug for cancer treatment.

Authors:  Yung-Chieh Chang; Min-Chieh Shieh; Yen-Hsuan Chang; Wei-Lun Huang; Wu-Chou Su; Fong-Yu Cheng; Chun Hei Antonio Cheung
Journal:  Int J Mol Med       Date:  2022-06-15       Impact factor: 5.314

5.  Photosubstitution in a trisheteroleptic ruthenium complex inhibits conjunctival melanoma growth in a zebrafish orthotopic xenograft model.

Authors:  Quanchi Chen; Jordi-Amat Cuello-Garibo; Ludovic Bretin; Liyan Zhang; Vadde Ramu; Yasmin Aydar; Yevhen Batsiun; Sharon Bronkhorst; Yurii Husiev; Nataliia Beztsinna; Lanpeng Chen; Xue-Quan Zhou; Claudia Schmidt; Ingo Ott; Martine J Jager; Albert M Brouwer; B Ewa Snaar-Jagalska; Sylvestre Bonnet
Journal:  Chem Sci       Date:  2022-05-16       Impact factor: 9.969

Review 6.  Zebrafish models of acute leukemias: Current models and future directions.

Authors:  Brandon Molina; Jasmine Chavez; Stephanie Grainger
Journal:  Wiley Interdiscip Rev Dev Biol       Date:  2020-12-19       Impact factor: 5.814

7.  Fishing for Contact: Modeling Perivascular Glioma Invasion in the Zebrafish Brain.

Authors:  Robyn A Umans; Mattie Ten Kate; Carolyn Pollock; Harald Sontheimer
Journal:  ACS Pharmacol Transl Sci       Date:  2020-12-17

Review 8.  Xmrks the Spot: Fish Models for Investigating Epidermal Growth Factor Receptor Signaling in Cancer Research.

Authors:  Jerry D Monroe; Faiza Basheer; Yann Gibert
Journal:  Cells       Date:  2021-05-07       Impact factor: 6.600

Review 9.  Cancer models in preclinical research: A chronicle review of advancement in effective cancer research.

Authors:  Humna Sajjad; Saiqa Imtiaz; Tayyaba Noor; Yusra Hasan Siddiqui; Anila Sajjad; Muhammad Zia
Journal:  Animal Model Exp Med       Date:  2021-03-29

Review 10.  Zebrafish, an In Vivo Platform to Screen Drugs and Proteins for Biomedical Use.

Authors:  Hung-Chieh Lee; Cheng-Yung Lin; Huai-Jen Tsai
Journal:  Pharmaceuticals (Basel)       Date:  2021-05-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.